Ensysce Biosciences, Inc. Quarterly Current Ratio in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ensysce Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2024.
  • Ensysce Biosciences, Inc. Current Ratio for the quarter ending September 30, 2024 was 204 %, a 113% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 204 +108 +113% Sep 30, 2024
Q2 2024 147 +67.3 +84.5% Jun 30, 2024
Q1 2024 164 +93.9 +134% Mar 31, 2024
Q4 2023 120 +37.6 +45.4% Dec 31, 2023
Q3 2023 96.1 +3.26 +3.51% Sep 30, 2023
Q2 2023 79.6 -27.5 -25.7% Jun 30, 2023
Q1 2023 70 -52.7 -42.9% Mar 31, 2023
Q4 2022 82.8 -36.3 -30.5% Dec 31, 2022
Q3 2022 92.8 -4.28 -4.41% Sep 30, 2022
Q2 2022 107 +30.6 +40% Jun 30, 2022
Q1 2022 123 +113 +1118% Mar 31, 2022
Q4 2021 119 +111 +1437% Dec 31, 2021
Q3 2021 97.1 +73.6 +314% Sep 30, 2021
Q2 2021 76.5 +39.4 +106% Jun 30, 2021
Q1 2021 10.1 -45.9 -82% Mar 31, 2021
Q4 2020 7.75 -115 -93.7% Dec 31, 2020
Q3 2020 23.5 -256 -91.6% Sep 30, 2020
Q2 2020 37.1 -418 -91.8% Jun 30, 2020
Q1 2020 56 -498 -89.9% Mar 31, 2020
Q4 2019 123 -570 -82.3% Dec 31, 2019
Q3 2019 280 -688 -71.1% Sep 30, 2019
Q2 2019 455 Jun 30, 2019
Q1 2019 554 Mar 31, 2019
Q4 2018 692 Dec 31, 2018
Q3 2018 968 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.